Pharmacological studies have shown that some of the active ingredients in these traditional Chinese medicines have anti-ALI/ARDS effects, such as Astragaloside IV in Radix Astragali which can alleviate LPS-induced acute lung injury by inhibiting the activation of NF-κB pathway and the expression of inflammatory genes [15]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.